Towards Healthcare Research & Consulting
U.S. Vaccines Market
Updated Date: 10 June 2026   |   Report Code: 6939

U.S. Vaccines Market the Race Toward Long-Term Healthcare Resilience

According to Rohan Patil, who specializes in therapeutic areas, biopharmaceuticals, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the U.S. vaccines market. The U.S. vaccines market size was estimated at USD 38.24 billion in 2025 and is predicted to increase from USD 39.88 billion in 2026 to approximately USD 58.26 billion by 2035, expanding at a CAGR of 4.3% from 2026 to 2035. His analysis highlights the growing importance of immunization programs, increasing investments in vaccine research and development, and rising demand for preventive healthcare solutions. The research also examines the competitive strategies of key industry participants, including Pfizer, Moderna, Merck & Co., GSK, Sanofi, and Johnson & Johnson, shaping the future of vaccine innovation and disease prevention across the U.S.

Last Updated : 10 June 2026 Category: Therapeutic Area Insight Code: 6939 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • U.S. Vaccines Market Analysis, By Vaccine Type
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Vaccines Market Analysis, By Technology
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Vaccines Market Analysis, By Route of Administration
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Vaccines Market Analysis, By Age Group
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Vaccines Market Analysis, By Disease Indication
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Vaccines Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Vaccines Market Analysis, By Distribution Channel
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Vaccine Type
      • By Technology
      • By Route of Administration
      • By Age Group
      • By Disease Indication
      • By End User
      • By Distribution Channel
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Company 1
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis

FAQ's

Answer : The U.S. vaccines market in 2026 is valued at USD 39.88 billion and is projected to climb to USD 58.26 billion by 2035, with a CAGR of 4.3% over the forecast period.

Answer : National Institutes of Health, FDA, WHO, PIB, CDC.

Answer : The report includes competitive analysis of leading industry participants such as Pfizer, Moderna, Merck, Sanofi, GlaxoSmithKline, and other significant market players, highlighting their strategies, product portfolios, partnerships, and recent developments.

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar